The effect of enalapril on advanced diabetic nephropathy in African-American females

Ethnicity and Disease

Volumn 11, Issue 2, 2001, Pages 211-216

  Crook, Errol D ^a,b   Harris, Jonathan ^a   Oliver, Bonnie ^a   Taylor, Robert ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

African American; Angiotensin converting Enzyme Inhibitor; Diabetic Nephropathy; Female; Renal Insufficiency

Indexed keywords

CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL;

AFRICAN AMERICAN; ARTICLE; BLOOD; DIABETIC NEPHROPATHY; ETHNOLOGY; FEMALE; HUMAN; MIDDLE AGED; UNITED STATES;

AFRICAN AMERICANS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CREATININE; DIABETIC NEPHROPATHIES; ENALAPRIL; FEMALE; HUMANS; MIDDLE AGED; MISSISSIPPI;

EID: 0035288950     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. US Renal Data System. USRDS 1998 Annual Data Report. Bethesda, Md: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1998.
2. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med. 1993;329:1456-1462.
3. Ravid M, Savin H, Jutrin I, Bental T, Katz B, Lishner M. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med. 1993;118:577-581.
4. Kshirsagar AV, Joy MS, Hogan SL, Falk RJ, Colindras RE. Effect of ACE inhibitors in diabetic and non-diabetic chronic renal disease: a systematic overview of randomized placebo-controlled trials. Am J Kidney Dis. 2000:35:695-707.
5. Lebovitz HE, Wiegmann TB, Cnaan A, et al. Renal protective effects of enalapril in hypertensive NIDDM: role of baseline proteinuria. Kidney Int Suppl. 1994;45:50(S155).
6. Bakris GL, Barnhill BW, Sadler R. Treatment of arterial hypertension in diabetic humans: importance of therapeutic selection. Kidney Int. 1992; 41:912-919.
7. Bennett PH, Haffner S, Kasiske BL, et al. Screening and management of microalbuminuria in patients with diabetes mellitus: recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee of the Council on Diabetes Mellitus of the National Kidney Foundation. Am J Kidney Dis. 1995;25:107-112.
8. Crook ED, Crenshaw G, Taylor R. Endstage renal disease due to diabetic nephropathy in African-American females: an examination of therapeutic, racial and gender factors in this population prone to late referral [abstact]. Ethn Dis. 1999;9:295.
9. American Diabetes Association. Position statement: diabetic nephropathy. Diabetes Care. 1999; 22(suppl 1):S66-S69.
10. Mogensen CE. Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. BMJ. 1982;285:685-689.
11. Parving HH, Andersen AR, Smidt UM, Svendsen PA. Early aggressive antihypertensive treatment reduces the rate of decline in kidney function in diabetic nephropathy. Lancet. 1983;1:1175-1179.
12. Ravid M, Brosh D, Ravid-Safran D, Levy Z, Rachmani R. Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. Arch Intern Med. 1998;158:998-1004.
13. Joint National Committee VI. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 1997;157:2413-2446.
14. Estacio RO, Jeffers BW, Hiatt WR, Biggerstaff SL, Gifford N, Schrier RW. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. N Engl J Med. 1998;338:645-652.
15. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000:342:145-153.